Introduction
The majority of the isolated tumor suppressor genes has been identi®ed in familial cancer syndromes. These genes are involved in diverse cellular processes such as transcriptional regulation, cell-cycle control, programmed cell death, and genetic stability (Fearon, 1997) . At least 50 tumor suppressor genes are suspected to exist in the human genome that predispose to familial cancer syndromes (Knudson, 1993) . In the development and progression of sporadic tumors multiple of such and still to be identi®ed tumor suppressor genes are inactivated.
On human chromosome 13, the retinoblastoma predisposing gene 1 (RB1) and the breast-cancer susceptibility gene 2 (BRCA2) have been identi®ed (Friend et al., 1986; Lee et al., 1987; Wooster et al., 1995) . While inactivating mutations of the BRCA2 gene seem to be mainly restricted to a familial-type of breast cancer, inactivating mutations of the RB1 gene have been detected in a variety of non-familial-type of cancers (Teng et al., 1996; Goodrich and Lee, 1993) . In lung carcinomas, loss of heterozygosity (LOH) on chromosome 13q14 at the RB1 locus has been frequently observed, however, only small cell lung carcinomas show a high frequency of RB1 inactivation (Harbour et al., 1988; Hensel et al., 1990) . The majority of non-small cell lung carcinoma cell lines (Shapiro et al., 1995) and primary tumors (Harbour et al., 1988; Sachse et al., 1994 , Tamura et al., 1997 show normal RB1 expression. A lack of correlation between LOH at the RB1 gene and loss of RB1 expression has also been demonstrated in various other sporadic cancers including head and neck cancer, carcinomas of the breast, ovary, and prostate suggesting the possible signi®cance of the RB1 gene in only a subset of these cancers (Yoo et al., 1994; Maestro et al., 1996; Borg et al., 1992; Kim et al., 1994; Cooney et al., 1996; Li et al., 1998) . The frequently observed LOH on chromosome 13q14 in tumor cells with normal RB1 expression indicates the presence of a tumor suppressor gene adjacent to the RB1 gene. We have identi®ed a candidate tumor suppressor gene (DICE1, for deleted in cancer 1) located in the critical region of LOH at 13q14.12-14.2 that shows loss or downregulation of expression in the majority of non-small cell lung carcinomas tested. The DICE1 gene encodes an evolutionarily highly conserved protein of 100 kD indicating an important cellular function. Identification of the DICE1 gene that appears to be involved in sporadic tumorigenesis may have important diagnostic, prognostic and therapeutic implications.
Results

Identi®cation of the DICE1 gene on human chromosome 13q14
A single-copy sequence was isolated from a region that is homozygously deleted in human lung carcinoma cell line SK-LC-17 ( Figure 1a ; Wieland et al., 1992; Wieland and BoÈ hm, 1994) . This single-copy sequence was used to generate PCR primers and to isolate P1 clones by PCR. Two sets of P1 clones were obtained that hybridized to the single-copy sequence (Figure 1b ). These two sets of P1 clones apparently do not crosshybridize in¯uoresence in situ hybridizations (Wieland et al., 1996; Figure 2) suggesting that the majority of unique sequences contained in the two sets are non-homologous. One set of P1 clones was derived from chromosome 5p12-13 (Wieland et al., 1996) and the other set was from chromosome 13q14.12-14.2 as shown by¯uorescence in situ hybridization (Figure 2 ). Since chromosomal region 5p12-13 as well as 13q14 show frequent LOH in lung carcinomas (Wieland et al., 1996; Tamura et al., 1997) suggesting the location of putative tumor suppressor genes, we determined whether the obtained P1 clones contain exon sequences by applying the exon ampli®cation method (Buckler et al., 1991; Church et al., 1994) . Amplification products containing potential exons were sequenced and PCR primers were designed to screen human cDNAs for expressed sequences. Two potential exons of 155 bp and 327 bp obtained from the P1 clones of chromosomal region 13q14.12-14.2 were successfully ampli®ed by this PCR screen. Hybridization of the 327 bp exon sequence to a zooblot detected single copy genes in genomic DNA of all mammalian species tested as well as in genomic DNA of chicken (Figure 3 ). This evolutionary high conservation independently suggested the existance of a gene from which the potential exon sequence has been derived.
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Figure 1 (a) Southern blot analysis of human lung carcinoma cell lines using a single-copy probe from a genomic region homozygously deleted in lung carcinoma cell line SK-LC-17. High molecular weight DNA was cleaved with HindII. (b) P1 clones derived from human chromosome 5 (P5234) and chromosome 13 (P5037) were analysed by Southern blotting using the single-copy probe homozygously deleted in cell line SK-LC-17. Puri®ed DNA was digested with NotI (lanes 1 and 3) and BamHI (lanes 2 and 4), respectively Cloning and sequence analysis of the DICE1 cDNA PCR primers deduced from the identi®ed exon sequences were used to screen a human fetal brain cDNA library. Several overlapping cDNA clones were isolated and sequenced. Both, the 155 bp and the 327 bp exon sequences are encoded by the overlapping cDNA clones (Figure 4a ). This cDNA crosshybridized to DNA on human chromosome 5 on a somatic hybrid panel and to the P1 clones isolated from chromosome 5p12-13 (data not shown) suggesting the location of a related gene in this region of frequent LOH on the short arm of chromosome 5 Wieland et al., 1996; BoÈ hm et al., 1997a; Peralta et al., 1998) .
The initiation site (GCCAGCACTATGC) shows some similarity to the Kozak consensus sequence for initiation of translation (Kozak, 1987 ). An in-frame stop codon (TAG) is located 86 bp upstream of the potential start site. The 3' untranslated region of the cDNA encompasses 529 bp including two mRNA destabilizing sequences located at nucleotide positions 3362 and 3619, and a consensus polyadenylation site (AATAAA) 17 bp upstream of a poly(A)
The open reading frame predicts a polypeptide sequence of 887 amino acids corresponding to a calculated molecular weight of 100 kD. Indeed, a protein of approximately 100 kD was generated by coupled in vitro transcription and translation of the DICE1 cDNA in rabbit reticulocyte lysates ( Figure  4b ), suggesting that the predicated initiation sequence serves as the start site of translation. In the aminoterminal part of the predicted protein a RGD sequence (starting at amino acid position 46) was found. A cAMP phosphorylation site (at amino acid position 460), a DEAD-box of ATP-dependent helicases (starting at amino acid position 629), a potential Nglycosylation signal (at amino acid position 707) were predicted in the carboxy-terminal part and several protein kinase C phosphorylation sites and nuclear sorting signals were predicted by the PROSITE motif search program. No signal peptide and transmembrane spanning region was predicted. While the RGD sequence is characteristic for extracellular domains of members of the integrin family, the other motifs indicate a cytoplasmic or nuclear localization of the DICE1 protein.
DNA sequence homology searches in the GenBank and dbEST databases using the BLAST search program (Altschul et al., 1994) revealed several dbEST sequences homologous or identical to the 5' and 3' ends of the DICE1 cDNA. A high degree of homology with 90.7% identity was detected from nucleotide position 816 to 3154 of the DICE1 cDNA to nucleotide position 3443 to 5771 of the mouse DBI-1 cDNA (Figure 4c ), a gene related to members of the notch family (Ho III et al., 1998) . This corresponds to an identity of 92.9% over 773 of the predicted amino acids. A low degree of homology (50.5% similarity, 27.6% identity) was detected to the amino acid sequence of F08B4.1 gene product from C. elegans cDNA YK25A9.5. Between these three proteins the most conserved region encompasses 330 amino acids from amino acids 114 to 444 of the DICE1 gene product (Figure 4c ). The human and mouse amino acid sequences are 92.8% identical and the human and C. elegans amino acid sequences are 32.7% identical within this region. Seven highly conserved domains consisting of 8 ± 12 amino acids and a domain of 16 amino acids with no apparent homology to known protein motifs are features of this conserved region.
Expression of DICE1 mRNA in normal tissue
The DICE1 cDNA hybridizes to a major transcript of 4.4 kb on Northern blots with poly(A) + RNA from adult human heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas ( Figure 5 ). This size agrees approximately with the length of the cloned DICE1 cDNA. A weaker hybridization signal at 6.9 kb is also apparent in all tissues. Both, the 4.4 kb and 6.9 kb transcripts are also expressed in human fetal heart, brain, lung, liver and kidney (data not shown). In adult heart, brain and skeletal muscle a smaller transcript of 4 kb is detected in addition to the major 4.4 kb transcript.
Downregulation of DICE1 mRNA expression in human non-small cell lung carcinomas Compared to normal adult lung expression of the DICE1 mRNA is reduced in most non-small cell lung carcinoma cell lines tested by Northern blot analysis (Figure 6a) . Furthermore, in cell line LX-1 the 6.9 kb transcript appears as a heterogenous band compared to normal lung tissue. Squamous cell carcinomas and adenocarcinomas of the lung microdissected by MOMeNT were analysed by semiquantitative RT ± PCR using PCR primers from the 5' coding region of the DICE1 cDNA that appeared to be speci®c for chromosome 13. Of four microdissected non-small cell carcinomas of the lung (Figure 6b ; P5, P11, P23, P31) with LOH at 13q14.1-q14.2 (at marker D13S263; Cooney et al., 1996) three (P5, P11, P23) showed absent expression of the DICE1 mRNA in the tumor cells compared to normal lung tissue. A reduced expression of the DICE1 mRNA was observed in a squamous cell carcinoma with LOH at marker D13S263 (Figure 6b ; P31) and in two non-small cell lung carcinomas without LOH at marker D13S263 (Figure 6b ; P38, P57).
Discussion
Molecular analyses have shown frequent allelic deletion on chromosome 13q14 without altered RB1 protein expression in a variety of sporadic tumors including carcinomas of the lung (Harbour et al., 1988; Sachse et al., 1994; Tamura et al., 1997) , head and neck (Yoo et al., 1994; Maestro et al., 1996) , breast (Borg et al., 1992) , ovary (Kim et al., 1994) and prostate (Cooney et al., 1996; Li et al., 1998) . Besides the predisposing cancer genes BRCA2 and RB1 two candidate tumor suppressor genes were previously identi®ed on human chromosome 13 for sporadic solid tumors (Schott et al., 1994; Garkavtsev et al., 1996) . These genes reside on chromosome 13q12-q13 (Brush1) and 13q33-q34 (ING1) (Schott et al., 1994; Garkavtsev et al., 1997) . Both, the Brush1 gene and the ING1 gene are reduced in expression in breast tumor cell lines compared to normal breast epithelial cells and both have been implicated in breast tumorigenesis (Schott et al., 1994; Garkavtsev et al., 1996) .
We have isolated the gene DICE1 located in chromosomal region 13q14 that has been de®ned as a commonly deleted region in various carcinomas. The DICE1 gene located in chromosomal region 13q14.12-14.2 is expressed in diverse human fetal and adult tissues. A major transcript of 4.4 kb and a transcript of 6.9 kb are detectable by Northern blot analysis. Adult heart, skeletal muscle and brain express a presumably alternative spliced version of 4 kb in addition to the major 4.4 kb transcript. This suggests alternative splicing of the DICE1 mRNA in a developmentally regulated and tissue speci®c manner. Whether this shorter transcript of the DICE1 mRNA re¯ects permanent growth arrest which is a common feature of cells from adult heart, skeletal muscle and brain needs to be further investigated. Compared to normal lung tissue, expression of the DICE1 mRNA is reduced in most non-small cell lung carcinoma cell lines. Loss of expression of the DICE1 mRNA occurred in resected squamous cell carcinomas and adenocarcinomas with LOH at 13q14 compared with normal lung tissue. This suggests that the DICE1 gene is a candidate tumor suppressor. The reduced expression of the DICE1 mRNA detected in two lung carcinomas without LOH at this chromosomal region may suggest that downregulation of the expression of the DICE1 gene is involved in tumorigenesis.
The deduced DICE1 protein of 100 kD contains a DEAD-box as the predominant motif. Members of the DEAD-box protein family are found in a wide range of organisms and individual members of the family have been highly conserved in evolution (Linder et al., 1989) . DEAD-box proteins of the ATP-dependent helicases show a number of conserved sequence motifs that appear to be responsible for speci®c functions of the proteins (Linder et al., 1989; 34) . These additional motifs characteristic for ATP-dependent helicases are not found in the predicted DICE1 protein and no homology to other members of the DEAD-box protein family was detected. This most likely excludes the DICE1 protein as a member of the ATP-dependent helicases and related proteins. Nevertheless, the high evolutionary conservation of the DICE1 gene suggests an important cellular function of the DICE1 protein.
The mouse DBI-1 cDNA encodes an EGF repeat transmembrane protein related to members of the notch family (Ho III et al., 1998) . The DBI-1 protein is nearly identical to the human DICE1 protein in its carboxy-terminal half, i.e. the EGF repeat domains and transmembrane spanning region are excluded while the DEAD-box motif is present in both proteins. The DBI-1 cDNA consists of 6.3 kb and hybridizes to a major transcript of approximately 6.5 ± 7 kb on Northern blots containing poly (A) + RNA of adult mouse tissues (Ho III et al., 1998) . This transcript is similar in size to the minor 6.9 kb transcript detected by the DICE1 cDNA on human Northern blots. This may indicate that the human 6.9 kb transcript is derived from the actual human homologue of DBI-1 (DICE2). The DICE1 cDNA also crosshybridized to the second set of isolated P1 clones (P5234 and P5235; data not shown) that were identi®ed by PCR and that were derived from a region homozygously deleted in a lung carcinoma cell line on human chromosome 5p13-12 (Wieland et al., 1996) . This region shows frequent LOH in lung, bladder and esophageal carcinomas (Wieland et al., 1996; BoÈ hm et al., 1997; Peralta et al., 1998) and may harbor the DICE2 gene. Although potential exon sequences were obtained from the chromosome 5-speci®c P1 clones by the exon ampli®cation method, a full-length chromosome 5-speci®c human cDNA homologous to the mouse DBI-1 cDNA could not be isolated, so far. This may be due to a low expression level of the corresponding mRNA, i.e. the minor 6.9 kb transcript detected by DICE1 on human Northern blots.
The DBI-1 cDNA was isolated by dierential display to examine the dierences in genes expressed between mouse cells expressing a wild-type, transforming insulin-like growth factor I receptor (IGF-IR) and mouse cells expressing a C-terminally truncated (7108 aa), non-transforming IGF-IR (Ho III et al., 1998) . Many human cancers overexpress the IGF-IR which appears to be required for their transformed phenotype (rev. in Werner and LeRoith, 1996) . In the lung, the IGF-IR is expressed in normal bronchial epithelial cells as well as in primary lung cancers and the ligand IGF-I appears to be the main autocrine growth factor in lung tumorigenesis. Mouse cells containing the wild-type IGF-IR grow anchorageindependent and express low levels of DBI-1 while mouse cells expressing the truncated IGF-IR grow anchorage-dependent and express elevated levels of DBI-1 (Surmacz et al., 1995; Ho III et al., 1998) . Furthermore, expression of exogenous DBI-1 cDNA in mouse cells containing the wild-type IGF-IR antagonized IGF-I stimulation (Ho III et al., 1998) . This may suggest that the DBI-1 gene is involved in anchorage-dependent growth by participating in the negative regulation of IGF-I signaling. Loss of anchorage-independent growth is characteristic for transformed cells (Folkman and Moscona, 1978) . By inactivation of the genes that maintain anchoragedependent growth tumor cells will gain additional growth advantages. This further supports the role of DICE1 as a tumor suppressor gene.
Materials and methods
Identi®cation of P1 clones
PCR primers D1a: 5'-GATAGATGAAGCAGATGAAT-3' and D1b: 5'-CTGGCTGTGCTTGAGTTGTA-3' were deduced from a single-copy sequence that is located in a region homozygously deleted in lung carcinoma cell line SK-LC-17 (Wieland et al., 1992; Wieland and BoÈ hm, 1994) . These primers produce a 200 bp ampli®cation product and they were used to screen a human P1 library (Genome Systems, Inc. St. Louis, MI, USA). Two sets of P1 clones were obtained: one set is speci®c for human chromosome 5 (Wieland et al., 1996) and is de®ned by PCR primers GD5a:
5'-CTAGTCGTTAACAAATCAGGTG-3' and GD5b: 5'-CGGAATCGACGTAAGGTAT-3', and the other set is speci®c for human chromosome 13 and is de®ned by PCR primers D2a: 5'-GACTGTTGTGATCTTGCA-3' and D2b: 5'-CTAGTTTAATGTATGTGCTT-3'.
Fluorescence in situ hybridization
Metaphase spreads from normal human lymphocytes were hybridized with nick translated P1 DNA using digoxigenin-11-dUTP (Boehringer Mannheim). Probe detection was accomplished with FITC-anti-digoxigenin conjugate (Oncor) as described (Wieland et al., 1996) .
Exon ampli®cation
Puri®ed DNA of P1 clones (Wieland et al., 1996) was digested with either BamHI, XboI or XhoI (Boehringer Mannheim) and the DNA fragments were ligated into pET01 exontrap vector (USB). The ligation reactions were transformed in E. coli XL-1 blue host. Plasmid DNA prepared from pooled recombinant clones was electroporated into Cos-7 cells as described (Buckler et al., 1991) . Total RNA was isolated 72 h post-transfection and reverse transcription (RT) was performed as described (Church et al., 1994) using the cDNA primer provided with the pET01 exontrap vector. One-fourth of the RT reactions was introduced as template in 50 ml polymerase chain reactions (PCR) using 5' and 3' PCR primers provided with the pET01 vector that contain BamHI and SmaI restriction enzyme sites, respectively. Ampli®cation with Taq Polymerase (1 U per 50 ml reaction; Boehringer Mannheim) was performed for 35 cycles at 948C for 1 min, 628C for 1 min and 728C for 2 min. PCR products were analysed by agarose gel electrophoresis and staining with ethidium bromide. For cloning, PCR products were digested with BamHI and SmaI and excised from low-melting-point agarose gels (SeaPlaqueGTG, FMC BioProducts) followed by digestion of the agarose gel with GElase (Epicentre Technologies) as recommended by the supplier. The puri®ed PCR products were cloned in plasmid vector pT7T3 (Pharmacia) and inserts were sequenced.
Screening of phage library
A human fetal brain 5'-strech plus cDNA library (Clontech) was prescreened by PCR using primers deduced from identi®ed exontrap sequences. PCR primers were commercially synthezised (MWG-Biotech). Phage pools containing 10 5 plaque forming units were introduced into 50 ml ampli®cation reactions. PCR conditions were as described . Positive pools were plated, ®lter lifts were hybridized with 32 P-labeled DNA probes and washed under standard conditions (Sambrook et al., 1989) . Positive plaques were rescreened by PCR and plaque lift hybridization. Single positive plaques were isolated and phage DNA was prepared using a kit (Qiagen). Inserts were recloned in plasmid vector pT7T3 and sequenced.
DNA sequencing
Single-run DNA sequencing was performed with¯uorescein-labeled dATP on an Automated Laser Fluorescent ALF DNA Sequencer (Pharmacia). Overlapping cDNA clones were sequenced on both strands commercially (Eurogentec, Seraing, Belgium) using vector primers or primers deduced from the obtained sequences. The cDNA sequence was analysed using DNAsis, sequence analysis software (Hitachi). PCR primer sequences GD5a and GD5b used to screen the the P1 library are contained in the the isolated cDNA.
In vitro transcription and translation
The DICE1 cDNA starting from nucleotide position 370 to the 3'end was cloned into expression vector pSG6 (KleinHitpass, unpublished), which is identical to pSG5 (Green et al., 1988) except for a modi®ed multiple cloning site downstream of the T7 bacteriophage promoter. Plasmid DNA was in vitro transcribed/translated with T7 RNA polymerase in the TNT coupled reticulocyte system (Promega) in the presence of [ 35 S]Methionine (Amersham) according to the manufactorer's recommendations. Two ml of the lysates were separated by SDS polyacrylamide gel electrophoresis. Gels were dried onto Whatman paper and exposed for 3 days to X-ray ®lms (BioMax MS, Amersham).
Southern and Nothern blots
Human lung carcinoma cell lines SK-LU-1, SW 900, and NCI-H520 were obtained from the American Type Culture Collection. Cell lines Vero129, NIH3T3, NRK, MDBK and MDCK were obtained from W Birchmeier (MDC, Berlin). All cell lines were obtained and cultivated as described (Wieland et al., 1992) . High molecular weight DNA from lung carcinoma cell lines and from cell lines Vero 129 (African green monkey), NIH3T3 (mouse), NRK (rat), CHO (hamster), MDBK (cow), MDCK (dog) and chicken embryo ®broblasts was prepared as described (Sambrook et al., 1989) . DNA for the zooblot was cleaved with PvuII (Boehringer Mannheim), electrophoresed through an 0.8% agarose gel and transfered to a nylon membrane (GeneScreenPlus, NEN/ Du Pont) as recommended by the supplier. DNA probes for Southern and Northern blot hybridization were labeled with 32 P-dCTP (Amersham) by random priming (Feinberg and Vogelstein, 1983) . The zooblot was hybridized overnight at 608C and washed in 26SSC and 0.1% SDS at 608C (Sambrook et al., 1989) .
Total RNA was isolated by the acid guanidinium thiocyanat-phenol-chloroform extraction procedure (Chomczynski and Sacchi, 1987) . Poly (A) + RNA was puri®ed using a kit (Qiagen). Poly (A) + RNA from normal human lung was purchased (Clontech). Of each Poly(A) + RNA preparation 3 mg was separated by formaldehyde gel electrophoresis and transfered to a nylon membrane (GeneScreenPlus, NEN/Du Pont) by capillary blotting as recommended by the supplier. The Multiple Tissue Northern (MTN) blot was purchased (Clontech). The Northern blots were hybridized in 50% formamide buer overnight at 428C, washed in 26SSC, 0.05% SDS at room temperature and twice in 0.16SSC, 0.1% SDS at 508C (Sambrook et al., 1989) .
Semiquantitative RT ± PCR of microdissected lung cancer specimens
Normal lung tissue, four squamous cell lung carcinomas and two adenocarcinomas were microdissected by MOMeNT as described (BoÈ hm et al., 1993 (BoÈ hm et al., , 1997b BoÈ hm and Wieland, 1997) . Microdissectates were lysed with proteinase K as described (BoÈ hm et al., 1993) . Immediately after inactivation of the proteinase K, 33 U RNasin (Promega) were added to the samples. RNA from one-fourth of the lysates was reverse transcribed using a mixture of oligo (dT)15 primer (Promega) and random hexanucleotides (Pharmacia). Reverse transcription (RT) was carried out in a ®nal volume of 20 ml with Superscript II (GIBCO ± BRL) as recommended by the supplier. Of the RT reactions 5 ml (corresponding to about ®ve cell equivalents) were used as templates in 50 ml PCRs. A 169 bp PCR product was speci®cally ampli®ed from the DICE1 cDNA using primers D3a: 5'-TGCCCATCT-TACTGTTCCTG-3' and D3b: 5'-TCTTCGAAAGTGAC-CAGC-3'. To monitor equivalent amounts of ®rst strand cDNA in the PCRs an 188 bp product from exons 7 and 8 of the houskeeping gene glyceraldehyde-3-phosphate dehydrogenase (G3PDH) was ampli®ed using primers 5'-TGGTATCGTGGAAGGACTCA-3' and 5'-ATGCCAGT-GAGCTTCCCGTT-3'. Ampli®cations were carried out with the Expand high ®delity PCR system (Boehringer Mannheim) in the presence of 2.5 mM MgCl 2 . PCR conditions for the DICE1 cDNA were 2 min at 958C for one cycle, 30 s at 948C, 30 s at 588C, 45 s at 728C for 40 cycles, followed by an additional extension for 10 min at 728C. PCR conditions for the G3PDH cDNA were 2 min at 958C for one cycle, 30 s at 948C, 45 s at 628C, 45 s at 728C for 29 cycles followed by an additional extension for 10 min at 728C. PCR products were analysed by agarose gel electrophoresis and staining with ethidium bromide.
